Psilocin O-Glucuronide | 514212-83-0

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: Psilocin O-Glucuronide
• 英文别名: (2S,3S,4S,5R,6S)-6-[[3-[2-(dimethylamino)ethyl]-1H-indol-4-yl]oxy]-3,4,5-trihydroxyoxane-2-carboxylic acid
• CAS: 514212-83-0
• 化学式: C₁₈H₂₄N₂O₇
• 分子量: 380.4
• InChiKey: QPZFVYCQQOLROG-RNGZQALNSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.8
• 重原子数：
  27
• 可旋转键数：
  6
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  136
• 氢给体数：
  5
• 氢受体数：
  8

文献信息

• Compositions and methods for enhancing neuroregeneration and cognition by combining mushroom extracts containing active ingredients psilocin or psilocybin with erinacines or hericenones enhanced with niacin
  申请人：Stamets Paul Edward

  公开号：US20180021326A1

  公开（公告）日：2018-01-25

  Methods and compositions are disclosed for enhancing neurogenesis, resolving neuropathy and improving neurological health and functioning using fungal extracts and their active ingredients, including species of mushrooms and mycelia containing psilocybin and psilocin, combined with erinacines and hericenones or fungal extracts containing those active ingredients, with the addition of nicotinic acid. The compositions may optionally be combined with nervine plants.
• PSILOCYBIN COMPOSITIONS
  申请人：Stamets Paul Edward

  公开号：US20190105313A1

  公开（公告）日：2019-04-11

  Methods and compositions are disclosed for enhancing neurogenesis, resolving neuropathy and improving neurological health and functioning using fungal extracts and their active ingredients, including species of mushrooms and mycelia containing psilocybin and psilocin, combined with erinacines and hericenones or fungal extracts containing those active ingredients, with the addition of nicotinic acid. The compositions may optionally be combined with nervine plants.
• COMPOSITIONS OF PSILOCYBIN AND ANALOGS
  申请人：STAMETS Paul Edward

  公开号：US20200375967A1

  公开（公告）日：2020-12-03

  Methods and compositions are disclosed for enhancing neurogenesis, resolving neuropathy and improving neurological health and functioning using fungal extracts and their active ingredients, including species of mushrooms and mycelia containing psilocybin and psilocin, combined with erinacines and hericenones or fungal extracts containing those active ingredients, with the addition of nicotinic acid. The compositions may optionally be combined with nervine plants.